Yourgene Health Plc

0.005 (2.44%)
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.005 2.44% 0.21 16,579,073 16:35:11
Bid Price Offer Price High Price Low Price Open Price
0.21 0.22 0.215 0.205 0.205
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Biotechnology Animal & Plant 37.56 -1.92 -0.30 - 1.53
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:11 UT 200,000 0.21 GBX

Yourgene Health (YGEN) Latest News (1)

Yourgene Health (YGEN) Discussions and Chat

Yourgene Health Forums and Chat

Date Time Title Posts
20/5/202007:42YourGene to Infinity2,121
04/5/202008:06Partnership with Novacyt 2
30/3/202008:20Yourgene Health at the UK Investor Show3

Add a New Thread

Yourgene Health (YGEN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Yourgene Health (YGEN) Top Chat Posts

Top Posts
Posted at 03/4/2023 19:11 by twix386
Let's get it done ffs, so that we and the share price can hopefully all move on.Dragging it out serves nobody and clearly LR isn't for falling on his sword unless he's pushed.The lack of news this last year. The funding fiasco. The vow of silence. The modest commercial news that Ranger is delivering, let alone creating a revolution.The demonstrable lack of competence.We were told about various negs on going in USA at various stages including advanced and of the biggest contract to date for Ranger and Taiwan divestment and Strategic investment both of which we seemed to pin our funding on until it became clear they would not arrive in time - hence distressed Placing -YET as if to show the mismanagement we are still waiting for any news!!The relentless disappointment is farcical!
Posted at 04/3/2023 11:36 by clark8004
Always the same. Sell, news drops. Hold in and despair as the share price is eroded day after day. Decide to take action sell and news drops.

I think there will be some real good news but its all too soon after the smash and grab cheap share raid. Who knows it never pans out the way you think!


Posted at 11/1/2023 17:41 by catch007
Birdie12: Good luck to you in your dealings with YGEN.

I lost complete faith in the BOD which imho lacks integrity and has deceived investors on its trading position hence I will not invest further in YGEN.

Like many PI's I have sustained losses having bought a decent holding on the potential particularly on US ranger prospects which the BOD continually talked up. Sadly I didnt sell on the declining share price however few if any expected a disaster fund raise at nominal value. Hopefully in time the share price will respond to better trading news but is unlikely to reach previous levels given the billions of shares now available!

I am not certain whether £6.8m net raise is enough to get YGEN through the coming months unless testing volumes increase hugely and cost savings are realised. Good IP, good product range ruined by a growth at all costs strategy and a CFO who has failed to exercise any financial diligence on an obvious revenue and cashflow gap!

Posted at 06/12/2022 12:02 by melton john
twix, I don't expect dilution by issuing more shares at this price. Why would they, they are nearly EBITDA break-even unless the wheels have come off since the trading update. I mentioned the £5M loan in my previous post 2845, if necessary they surely would top that up.

"reduce its operating costs by £5m" "positive adjusted EBITDA in the next financial year".

"newsflow and comment completely invisible?" REALLY??? I don't know what you expect of a growing, small cap company on AIM after the last years. I've read last years list of RNS and anything remotely material has been reported unless you can point me to a definite omission.

I have a company comparison tool which compares over 30 metrics in different companies in the Biotechnology & Medical Research industry. One which compared almost equally was hVivo (HVO) formerly Open Orphan and until very recently their price charts followed very similar downward paths. The difference being one has a bunch of ex Viology shareholders with no patience left.
Another comparison I did was comparing valuations using the same tool. The result put Ygen on a combined valuation score of 80/100 with its neighbours, when listing in order of EV/EBITDA, on 18/100 and 19/100. The implication being that with the other two the good news was already baked in. The other two were BVXP and HVO. I'm very familiar with BVXP so I would agree that its a great company that I should have bought years ago but buying YGEN at current price is a no brainer.
Disclaimer, this isn't investment advice, just my reasons for buying more.

Posted at 05/12/2022 18:43 by twix386
Shaun Day, MD at Greatland Gold invites you all to come and see him present and take Q&A at his fourth London Town Hall of the year next Wednesday. A great opportunity to catch up 1-1 on progress. Please register here.    Share PricesYourgene Share PriceYourgene Share ChatYourgene Share Chat (YGEN)YGEN SharePriceYGEN ShareNewsYGEN ShareChat4YGEN ShareTrades26YGENLive RNSYGEN Information  Buy YGEN SharesAdd YGEN to WatchlistAdd YGEN to AlertAdd YGEN to myTerminal Share Price Information for Yourgene (YGEN) Share Price is delayed by 15 minutesGet Live DataShare Price:2.05Bid:2.00Ask:2.10Change: -0.10 (-4.65%) Spread: 0.10 (5.00%)Open: 2.05High: 2.05Low: 2.05Prev. Close: 2.05Last checked at 18:42:56Share Discussion for YourgeneRegular Premium Filters Post MessageView All Yourgene (YGEN) Share Chat2550100twix386Posts: 6,424Price: 2.05No OpinionRE: Let's dream (which can come true)Today 18:42going by previous form we are waiting to issue Results once funding in whatever chosen form is secured. Then we get news of both together or just days apart.Meanwhile the medicine (silence) is worse than the cure (funding) when this interminable lack of news and comment festers on trashing the share price. Another REALLY REALLY POOR SITUATION that requires much better!Get it done and/or say something ffs
Posted at 22/11/2022 23:49 by catch007
Melton John: I felt 13% fall in share price was indeed a steep fall, hardly describe that as tripe. My question was posed to elicit some sensible views re the current position especially around the cash position which was not stated in recent TU.

I was and remain positive around Ranger applications. The core YGEN business model is a volume orientated testing play so recent US partnerships need to deliver in H2 to generate cash. I really see little value or merit in discussing whether opening or closing prices re 2.5p or 2.6p both are irrelevant, more valuable is the future direction of travel of YGEN share price Like you I am a LTH of YGEN I may add again once more certainty is available however despite your Stockopedia data (thank you) there remains much confusion and conjecture at present as to the true prospects of the company at present.

Posted at 08/11/2022 19:41 by ngen yap
Still here Twix.Poor management of share price performance.Credible execution of business plan and strategy, with room for improvement.Let's hope the gap between the two will close.I remain confident of YGEN future and certainly consider it great value at this share price.If I had £20m, or even £10m, I would love to take control of it.But I hope someone will snap us up at a huge premium. Don't mind a cash + stock deal to stay in the ride. I like EKF actually, and can see lots of synergies. Perhaps they can :-)
Posted at 01/11/2022 16:22 by ngen yap
If I were Labcorp, I would just buy YGEN - can probably snap us up for $150m given our share price Not only can they save on future royalties to Ravgen (subject to appeal), they can switch over total NIPT customer to IONA Nx so preserving sales, improving margins and better accuracies.Additionally, they can utilise Ranger tech across all their other tests. Again improving performance and saving money.Then commercialise it via licensing + sales of reagents and consumables.The $150m will pay back very quickly plus more........Given the company's nonchalant attitude to share price performance, I suspect they know the "end game".
Posted at 26/4/2022 21:21 by sapporo59

Price: 9.25

Strong Buy

RE: RNS X 2!Today 20:26
Loved every bit of the presentation. Understand so much more about the company, its offering, differentiation/USP and route to market. Hang tight as share price is not reflective of its value, I strongly believe. Will write more in due course.
One thing to clarify. I had the privilege to sit next to Dr Bill Chang. Said hello and contrary to whoever that posted, he hasn't offloaded a single share and don't intend to until.......


Price: 9.25

No Opinion

RE: RNS X 2!Today 19:49
I was basically encouraged. A lot of info re two of the main products. State side is already into one of the super labs and working on another re NIPT. The Ex5 takeover is paying real service dividends compared to what we paid for it. If the share price does not rise to much this week I will top-up.


Price: 9.25

No Opinion

RE: RNS X 2!Today 19:06
Didn’t listen in its entirety as lost the will with the tech explanations. What struck me most was the chap who flew in from the US, busily outlining how many takeovers and mergers the sector has undergone and, as far as I could ascertain, as good as putting out an open invitation to any out there to come and buy us, preferably at a substantial premium of course.
Ygen seems to have so many products it is difficult to see decent market penetration any time soon in any specific area.
The Ranger tech is portrayed as the jewel in the crown which might eventually tempt one of the bigger players to swallow us as a morsel.
In the meantime, the Waiting for Godot scenario remains the order of the day.


Price: 9.25

No Opinion

RE: RNS X 2!Today 18:11



Price: 9.25

No Opinion

RE: RNS X 2!Today 18:11
This is the presentation talked to, yes there will be a recording and the Q&A will be answered.


Price: 9.25

No Opinion

RE: RNS X 2!Today 18:09
Wow how is it that we have so few people here and these meetme's happen maybe twice a year and are then are missed. priorities guys, you've known for weeks.

Most important point for me, even though LR acknowledged that questioned had come through whilst online - they were not addressed, we are told they will be in the writeup. Only two questions even asked and one answered by the question, jeez!!

Mostly presentations of case studies, Ok they weren't boring however Dr Rachel Shelmerdine lacked intonation, was slightly monotone and actually sounded like she should be in bed with an inhalation. Lots of presenting about the products, Ranger actually look very good. We are selling now in the US and may have large advantage in our advanced process over other current testing, a good example given was in providing the blood for testing EDTA tubes i.e. when taking blood our system only need one tube taken and that gives enough for 5 tests, other systems need labs to take two vials of blood as they need the lot for only one test, so they take two vials in case one is spoiled. Takes the cost of providing the sample from around $8 to $20 that's at the test providers expense, so its in financial interest for the people to use the cheapest system more profit for them. Thus our technology, pretty much across the board are both our own IP AND the most advanced AND potentially the cheapest for the customer win, win, win.

Lots shown including marketing film etc around ranger tech, looks good. Actually if I wasn't already a shareholder, there was enough there to make me want to do a bit more digging. But to be honest as presenters go, Scott was good, Bhavika was good, Rachel needs some rest!

Potential to take advantage of our IP. Big Markets, Big opportunity. Latin America could also be exciting. too much to take in, not really a presentation for me, better for a team of medical decision makers, oncologists, hospitals etc.

I just want to know when my shares are going to be worth at least what I paid for them so I can reassess whether to hold or fold.!!!!

Posted at 12/12/2021 13:34 by catch007
I am hopeful that on Tuesday we will get a progressive update from YGEN. The run rate for testing I suspect remains very strong and testing volumes will be driving revenue growth. I note several Covid testing stocks AVCT, ODX etc have been marked down heavily in recent months and Covid sentiment may well have also impacted YGEN share price though it is not a one trick pony with a strong NIPT business.

Looking for some positive framework news as it has been a 4 lot damp squib to date and also confirmation of US partners will be helpful. Unfortunately we may see further delays in global business growth with further Covid restrictions being imposed. Hoping that we may see recovery from the 12p range on the back of results. GLA

Yourgene Health share price data is direct from the London Stock Exchange
Your Recent History
Yourgene H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230606 17:39:36